Literature DB >> 24710744

Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand.

Y Perrot1, F Degoul, P Auzeloux, M Bonnet, F Cachin, J M Chezal, D Donnarieix, P Labarre, N Moins, J Papon, L Rbah-Vidal, A Vidal, E Miot-Noirault, L Maigne.   

Abstract

The GATE Monte Carlo simulation platform based on the Geant4 toolkit is under constant improvement for dosimetric calculations. In this study, we explore its use for the dosimetry of the preclinical targeted radiotherapy of melanoma using a new specific melanin-targeting radiotracer labeled with iodine 131. Calculated absorbed fractions and S values for spheres and murine models (digital and CT-scan-based mouse phantoms) are compared between GATE and EGSnrc Monte Carlo codes considering monoenergetic electrons and the detailed energy spectrum of iodine 131. The behavior of Geant4 standard and low energy models is also tested. Following the different authors' guidelines concerning the parameterization of electron physics models, this study demonstrates an agreement of 1.2% and 1.5% with EGSnrc, respectively, for the calculation of S values for small spheres and mouse phantoms. S values calculated with GATE are then used to compute the dose distribution in organs of interest using the activity distribution in mouse phantoms. This study gives the dosimetric data required for the translation of the new treatment to the clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710744     DOI: 10.1088/0031-9155/59/9/2183

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  4 in total

Review 1.  Preclinical Voxel-Based Dosimetry in Theranostics: a Review.

Authors:  Arun Gupta; Min Sun Lee; Joong Hyun Kim; Dong Soo Lee; Jae Sung Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-04-19

2.  Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.

Authors:  Latifa Rbah-Vidal; Aurélien Vidal; Emilie M F Billaud; Sophie Besse; Isabelle Ranchon-Cole; Florence Mishellany; Yann Perrot; Lydia Maigne; Nicole Moins; Jean-Luc Guerquin-Kern; Françoise Degoul; Jean-Michel Chezal; Philippe Auzeloux; Elisabeth Miot-Noirault
Journal:  Neoplasia       Date:  2016-12-14       Impact factor: 5.715

3.  Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.

Authors:  Hussein Akil; Mercedes Quintana; Jérémy H Raymond; Tommy Billoux; Valentin Benboubker; Sophie Besse; Philippe Auzeloux; Véronique Delmas; Valérie Petit; Lionel Larue; Michel D'Incan; Françoise Degoul; Jacques Rouanet
Journal:  Cancers (Basel)       Date:  2021-03-20       Impact factor: 6.639

4.  Biodistribution and internal radiation dosimetry of a companion diagnostic radiopharmaceutical, [68Ga]PSMA-11, in subcutaneous prostate cancer xenograft model mice.

Authors:  Su Bin Kim; In Ho Song; Yoo Sung Song; Byung Chul Lee; Arun Gupta; Jae Sung Lee; Hyun Soo Park; Sang Eun Kim
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.